StockVS

Translational Development Acquisition Corp. (TDAC) Aandelenanalyse

Financiële Diensten

Translational Development Acquisition Corp.

$10.64

+$0.00 (+0.00%)

Laatst bijgewerkt: 26 mei 2026

Koersverloop

Analyse

Bedrijfsoverzicht

Translational Development Acquisition Corp. is an entity structured without significant current operations, primarily intending to execute a business combination through mechanisms such as mergers, amalgamations, share exchanges, or asset acquisitions with one or more target businesses. The company operates within the Financial Services sector, specifically categorized under the industry of Shell Companies, which implies a special purpose acquisition vehicle (SPAC) status pending its initial public offering completion. At the time of the latest data, the entity holds a market capitalization of $232.22M, while its annual revenue and total employee count are not available as the company has not yet generated substantial commercial revenue or hired a full operational workforce. The current market capitalization of $232.22M indicates that the company's valuation is derived almost entirely from its potential future business combinations rather than historical financial performance or existing cash flows, reflecting the speculative nature of the shell company structure before a target is identified.

Financiële gezondheid

The company reports a net income of $6.36M for the trailing twelve months, whereas revenue and EBITDA figures are not available, revealing a financial structure where accounting profits exist independently of recorded revenue streams, likely due to non-operating income or specific SPAC accounting treatments. Free cash flow stands at $-254,185, indicating a negative cash generation position typical for shell companies that incur costs related to maintaining their public listing and preparing for a merger rather than funding operational expansion. All three margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, which signifies that the company has not yet engaged in revenue-generating activities that would allow for the calculation of meaningful operational profitability ratios. The balance sheet shows a cash position of $29,787 against a debt level of $200,000, suggesting a highly leveraged position relative to liquid assets, although the debt-to-equity ratio is not explicitly calculated in standard metrics. The current ratio is reported at 0.07, which indicates severe short-term liquidity constraints, as the company possesses significantly fewer current assets than current liabilities, making it unable to cover immediate obligations without external financing. Return on equity is not available, but return on assets is -0.3%, demonstrating that for every dollar of assets held, the company is currently destroying value rather than generating returns, a common characteristic during the pre-merger phase of such entities.

Waarderingsbeoordeling

The trailing twelve-month P/E ratio is 36.55, while the forward P/E is not available, a disparity that implies market expectations for future earnings are undefined or potentially volatile given the company's lack of a confirmed business target. The price-to-book ratio is listed at -7.54, a negative figure that indicates the market value is significantly below the book value, often seen in shell companies where assets are undervalued or liabilities outweigh the net asset value on a per-share basis. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are both marked as not available, suggesting that traditional valuation multiples cannot be applied to this entity until it transitions from a shell company to an operating business with tangible sales and earnings. The stock has traded between a 52-week high of $10.60 and a 52-week low of $10.09, placing the current trading range in a very narrow band that reflects the limited price discovery typical of SPACs with no specific merger partner. The beta value is not available, which means that the stock's volatility relative to the broader market cannot be quantified, though the narrow trading range suggests the price remains relatively stable around the $10 threshold often associated with SPAC trusts.

Growth & Income

Revenue growth and earnings growth rates are both not available due to the lack of historical revenue data and the company's current status as a shell entity, preventing any analysis of whether earnings are growing faster or slower than revenue. The company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, indicating that all available earnings are retained within the entity to fund the search for a merger target rather than being distributed to shareholders. Since the entity reinvests its capital into the process of identifying and completing a business combination rather than paying out income, the growth profile is entirely dependent on the successful execution of a future merger rather than organic business expansion. Consequently, the overall growth and income profile is characterized by an absence of current income generation and undefined growth trajectories until a definitive business combination is announced and integrated into the company's operations.

Vergelijking met sectorgenoten

Translational Development Acquisition Corp. (TDAC) is actief in de Lege Vennootschappen-sector. Zo verhoudt het zich tot de naaste sectorgenoten op basis van marktkapitalisatie:

Bedrijf Ticker Marktkapitalisatie K/W-verhouding
Translational Development Acquisition Corp. TDAC $233.10M 38.0
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

De gemiddelde K/W-verhouding in de Lege Vennootschappen-sector is 82.8x. Translational Development Acquisition Corp. wordt verhandeld tegen een K/W van 38.0.

Deze analyse is gegenereerd door AI en dient alleen ter informatie. Het vormt geen financieel advies. Gegevens kunnen vertraagd of onnauwkeurig zijn. Doe altijd je eigen onderzoek en raadpleeg een gekwalificeerde financieel adviseur voordat je beleggingsbeslissingen neemt.

Over Translational Development Acquisition Corp.

Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

Bedrijfsbeschrijving wordt in het Engels weergegeven.

Bezoek website →

Belangrijke Cijfers

Marktkapitalisatie
$233.10M
K/W-verhouding
38.00
52-weken hoog
$10.69
52-weken laag
$10.19
Gem. Volume
8.82K

Gegevens verstrekt door Yahoo Finance via yfinance. Dagelijks bijgewerkt.

Bedrijfsinfo

Beurs
NASDAQ
Land
United States